|
- Immunotherapy for Cancer - NCI
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer Learn about the types of immunotherapy and what you can expect during treatment
- Immune Checkpoint Inhibitors - NCI - National Cancer Institute
Immunotherapy drugs called immune checkpoint inhibitors work by blocking checkpoint proteins from binding with their partner proteins This prevents the “off” signal from being sent, allowing the T cells to kill cancer cells One such drug acts against a checkpoint protein called CTLA-4
- AI Tool May Help Guide Use of Cancer Immunotherapy - NCI
A class of immunotherapy drugs called immune checkpoint inhibitors have proven transformative for people with some types of cancer In a small number of patients with advanced forms of melanoma, lung cancer, and other tumor types, deposits of cancer scattered throughout their bodies simply melt away
- Definition of immunotherapy - NCI Dictionary of Cancer Terms
Immunotherapy uses the body’s immune system to fight cancer This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors
- Side Effects of Immunotherapy - NCI - National Cancer Institute
Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body Learn about the types of side effects that immunotherapy might cause and where to go for more information
- Cancer Treatment Vaccines - Immunotherapy - NCI
Cancer treatment vaccines are a type of immunotherapy that treats cancer by strengthening the body’s natural defenses against the cancer Unlike cancer prevention vaccines, cancer treatment vaccines are designed to be used in people who already have cancer—they work against cancer cells, not against something that causes cancer
- Immunotherapy Combo Approved for dMMR Colorectal Cancer
The Food and Drug Administration (FDA) has approved the combination of two immunotherapy drugs for the initial treatment of some people with advanced colorectal cancer
- Nivolumab - NCI - National Cancer Institute
Nivolumab works by binding to and blocking the protein PD-1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system This allows the immune system to attack the cancer cells Nivolumab is a type of immunotherapy drug called an immune checkpoint inhibitor
|
|
|